Forensic Science South Australia (FSSA) is seeking Requests for Proposals for the provision, implementation and ongoing support of a Commercial Off The Shelf (COTS) Forensic Laboratory Information Management System as detailed in the Request for Proposal documents.
CSols, Inc. Webinar: Find out how you can build upon your current LIMS implementation to further improve the operational efficiency of your laboratory and produce returns that satisfy both upper management and regulatory bodies.
On a typical day, I spend at least a few minutes browsing this blog and the LABVANTAGE social communities on LinkedIn, Twitter and Facebook. I’m looking to see who is talking about what and who is new. While browsing our LinkedIn group, I noticed something a bit out of the ordinary. In a community composed of customers, employees and other interested followers from all over the world, I noticed a new member of the latter type who had much in common with me. His name is Jon Wetzel, and it turns out that, like me, he lives in Southeast Michigan and is a graduate of my alma mater, Michigan State. Go Spartans!
Sparta Systems, Inc., the maker of TrackWise® quality management software and the market leader in enterprise quality and compliance management solutions, today announced the availability of On-demand TrackWise Training, a new solution designed to provide a cost-effective, convenient way for companies to train large groups of users and intermittent users on the basics of TrackWise Enterprise Quality Management Software (EQMS).
IDBS, a global provider of innovative data management, analytics and modeling solutions, today announced the availability of The Biomolecular Hub, a comprehensive data management solution for Omics data and analysis results.
Radiochromatography and nuclear medicine professionals in Spain, the Czech Republic and Singapore now have local access to software and instrumentation from LabLogic Systems following the appointment of new distributors.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that IDG’s Computerworld Honors Program has selected it as a 2011 Laureate. The annual award program honors organizations that create and use information technology to promote and advance public welfare, contribute to the greater good of society and change the world for the better.
Biomolecular drugs (Biologics – therapeutic proteins and Mabs) have leveled the playing field – a) about as many new biologics being approved each year as new small molecule drugs (NMEs); b) all the big Pharma now have the capacity to develop both types of drugs (note the recent buy-out of Genzyme by Sanofi-Aventis), c) those that had biologics capacity are increasing it., d) the larger biotech companies are developing the capacity to develop small molecules, and e) now with many blockbuster biologics nearing patent expiration biosimilars are on the way. It’s no longer - choose which type – you will need to know how to discover and develop either type of drug. This is a crash course on the differences and similarities between small molecule and biomolecular drugs for everyone who needs to know.
Questions or Comments? We'd like to hear your comments and suggestions. E-mail your feedback or questions to us at firstname.lastname@example.orgCopyright Laboratory Informatics Institute, Inc. All rights reserved.
Laboratory Informatics Institute, Inc. P.O. Box 813301 Smyrna, GA 30081 770-313-8185